Home
    • Plans Blog Contact
    DaVita HealthCare Partners Inc logo

    DaVita HealthCare Partners Inc

    DVA
    Last price US$235.99
    Market cap US$15.7b
    12M price change 62.88%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Universal Health Services IncUHS Industry peer CHEMED CORPCHE Industry peer Tenet HealthcareTHC Industry peer Zoetis IncZTS Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    DaVita HealthCare Partners Inc Overview

    Industry: Medical Care Facilities

    Sector: Healthcare

    DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodial Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for DaVita HealthCare Partners Inc into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed May 05, 2026

    Quarterly result summary

    Revenue was $3.4B (reported). Operating income was $482M. Net loss was -$2.

    Revenue $3.4B reported
    Operating income $482M reported
    Net loss -$2 reported
    Net income $198M -15% YoY

    What changed

    • Revenue reported to $3.4B.
    • Capital return update: free cash flow $140M.
    • Net income -15% YoY to $198M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 8-K May 05, 2026 SEC filing 10-Q May 05, 2026 SEC filing 10-K Feb 11, 2026 SEC filing 8-K Feb 02, 2026 Earnings release Earnings release Feb 02, 2026 SEC filing 10-Q Oct 29, 2025 SEC filing 8-K Oct 29, 2025 Earnings release Earnings release Oct 29, 2025 SEC filing 8-K Aug 05, 2025 Earnings release Earnings release Aug 05, 2025 SEC filing 10-Q Aug 05, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 4.00/5
    DaVita HealthCare Partners Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    In Medical Care Facilities industry , Universal Health Services Inc , CHEMED CORP , Tenet Healthcare are companies with high ratings.

    Return on Equity

    Score 3.81/5
    DaVita HealthCare Partners Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    DaVita Healt... DVA US$15.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Net Margin

    Score 4.61/5
    DaVita HealthCare Partners Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc
    DaVita Healt... DVA US$15.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Share Buyback

    In Medical Care Facilities industry , Universal Health Services Inc , CHEMED CORP , Tenet Healthcare are companies with high ratings.

    Leverage

    Score 1.11/5
    DaVita HealthCare Partners Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Agilent Technologies Inc have achieved high scores.
    DaVita Healt... DVA US$15.7b
    Zoetis Inc ZTS US$31.9b
    IQVIA Holdin... IQV US$34.8b
    Agilent Tech... A US$37.9b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    DaVita HealthCare Partners Inc logo

    DaVita HealthCare Partners Inc

    US$235.99

    US$182.81

    -22.5% vs price

    US$15.7b

    -0.61%

    62.88%